myocardial ischemia reperfusion injury
Conditions
Interventions
None listed
Sponsors
Shaanxi University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: MIRI Group: (1) Meet the diagnostic criteria of the European Society of Cardiology Guidelines 2023 for non-ST elevation acute coronary syndromes; (2) PCI and implantation of at least one stent within one week; (3) Race, gender, age =18 years old, < 85 years old; (4) Voluntarily participate in the study and sign the informed consent. Healthy subject group (1) Healthy body, no cardiovascular system disease, no mental disease; (2) Race, gender, age =18 years old, < 85 years old; (3) Voluntarily participate in the study and sign the informed consent. Note: Only those who meet the above criteria can be included in this study.
Exclusion criteria
Exclusion criteria: MIRI Group: (1) In STEMI patients, the ECG showed continuous ST segment elevation (at least two consecutive ST segment elevations from point J: ?V2 to V3 leads =2.5mm, male < 40 years old, or =2mm, male =40 years old, or =1.5mm, female no age; (2) Other leads =1mm, except left ventricular hypertrophy or left bundle branch block; ? Right chest lead V3R ~ V4R, or back lead V7 ~ V9=0.5mm); (2) Suffering from malignant tumors, severe infectious diseases, inflammatory diseases, autoimmune diseases, blood system diseases, acute cerebral infarction; (3) Patients with bullosa skin disease, granulomatous skin disease, metabolic skin disease, and connective tissue disease that are difficult to diagnose clinically; (4) Participate in any other drug study or treatment study using an unapproved drug within the previous 3 months; (5) Pregnant and lactating women; (6) suffering from mental illness or accompanied by serious psychological disorders, unable to cooperate; Note: Patients who meet any 1 of the above criteria will be excluded. Healthy subjects Group: (1) Anxiety, depression, cognitive disabilities, allergies; (2) Pregnant and lactating women; (3) Participants in other clinical trials. Note: Patients who meet any 1 of the above criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The skin change shape;Skin temperature; Value of resistance;Tenderness threshold; | — |
Countries
China
Contacts
Public ContactQiao haifa
Shaanxi University of Traditional Chinese Medicine
Outcome results
None listed